Conference Proceedings

SYMBIOTIC RELATIONSHIP BETWEEN A RESEARCH-INSTITUTE AND A PHARMACEUTICAL COMPANY - THE BAKER-INSTITUTE GLAXO-AUSTRALIA STORY

JA ANGUS

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | BLACKWELL SCIENCE | Published : 1992

Abstract

1. The Baker Medical Research Institute is a non-profit, charitable institution to advance knowledge and solve problems in the area of cardiovascular medicine. This allows scientists to collaborate within a critical mass and be flexible in their approach to research. 2. The Institute has interactions with the pharmaceutical industry at three levels: (i) contract research on a specific molecule; (ii) clinical trials; and (iii) collaborative basic research agreements. 3. The Glaxo Australia-Baker Medical Research Institute Agreement is for curiosity driven research in specified areas of vascular pharmacology of interest to Glaxo Group Research. 4. The relationship between universities, researc..

View full abstract

University of Melbourne Researchers